These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30386211)

  • 1. Role of the Fractalkine Receptor in CNS Autoimmune Inflammation: New Approach Utilizing a Mouse Model Expressing the Human CX3CR1
    Cardona SM; Kim SV; Church KA; Torres VO; Cleary IA; Mendiola AS; Saville SP; Watowich SS; Parker-Thornburg J; Soto-Ospina A; Araque P; Ransohoff RM; Cardona AE
    Front Cell Neurosci; 2018; 12():365. PubMed ID: 30386211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological depletion of microglia alleviates neuronal and vascular damage in the diabetic CX3CR1-WT retina but not in CX3CR1-KO or hCX3CR1
    Church KA; Rodriguez D; Mendiola AS; Vanegas D; Gutierrez IL; Tamayo I; Amadu A; Velazquez P; Cardona SM; Gyoneva S; Cotleur AC; Ransohoff RM; Kaur T; Cardona AE
    Front Immunol; 2023; 14():1130735. PubMed ID: 37033925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective fractalkine-CX3CR1 signaling aggravates neuroinflammation and affects recovery from cuprizone-induced demyelination.
    Mendiola AS; Church KA; Cardona SM; Vanegas D; Garcia SA; Macklin W; Lira SA; Ransohoff RM; Kokovay E; Lin CA; Cardona AE
    J Neurochem; 2022 Sep; 162(5):430-443. PubMed ID: 35560167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
    Niessner A; Marculescu R; Haschemi A; Endler G; Zorn G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
    Thromb Haemost; 2005 May; 93(5):949-54. PubMed ID: 15886814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin.
    Sunnemark D; Eltayeb S; Nilsson M; Wallström E; Lassmann H; Olsson T; Berg AL; Ericsson-Dahlstrand A
    J Neuroinflammation; 2005 Jul; 2():17. PubMed ID: 16053521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation.
    Garcia JA; Pino PA; Mizutani M; Cardona SM; Charo IF; Ransohoff RM; Forsthuber TG; Cardona AE
    J Immunol; 2013 Aug; 191(3):1063-72. PubMed ID: 23817416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the dorsal root ganglia and spinal cord in experimental autoimmune encephalomyelitis: implications in multiple sclerosis-induced neuropathic pain.
    Zhu W; Acosta C; MacNeil B; Cortes C; Intrater H; Gong Y; Namaka M
    Biomed Res Int; 2013; 2013():480702. PubMed ID: 24175290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of Fractalkine Signaling Leads to Microglial Activation and Neuronal Damage in the Diabetic Retina.
    Cardona SM; Mendiola AS; Yang YC; Adkins SL; Torres V; Cardona AE
    ASN Neuro; 2015; 7(5):. PubMed ID: 26514658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractalkine Signaling Attenuates Perivascular Clustering of Microglia and Fibrinogen Leakage during Systemic Inflammation in Mouse Models of Diabetic Retinopathy.
    Mendiola AS; Garza R; Cardona SM; Mythen SA; Lira SA; Akassoglou K; Cardona AE
    Front Cell Neurosci; 2016; 10():303. PubMed ID: 28119571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.
    McDermott DH; Fong AM; Yang Q; Sechler JM; Cupples LA; Merrell MN; Wilson PW; D'Agostino RB; O'Donnell CJ; Patel DD; Murphy PM
    J Clin Invest; 2003 Apr; 111(8):1241-50. PubMed ID: 12697743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulated fractalkine (FKN) and its receptor CX3CR1 are involved in fructose-induced neuroinflammation: Suppression by curcumin.
    Xu MX; Yu R; Shao LF; Zhang YX; Ge CX; Liu XM; Wu WY; Li JM; Kong LD
    Brain Behav Immun; 2016 Nov; 58():69-81. PubMed ID: 26765996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome Proliferator-Activated Receptor-δ Deficiency in Microglia Results in Exacerbated Axonal Injury and Tissue Loss in Experimental Autoimmune Encephalomyelitis.
    Doroshenko ER; Drohomyrecky PC; Gower A; Whetstone H; Cahill LS; Ganguly M; Spring S; Yi TJ; Sled JG; Dunn SE
    Front Immunol; 2021; 12():570425. PubMed ID: 33732230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internal carotid artery occlusive disease and polymorphisms of fractalkine receptor CX3CR1: a genetic risk factor.
    Ghilardi G; Biondi ML; Turri O; Guagnellini E; Scorza R
    Stroke; 2004 Jun; 35(6):1276-9. PubMed ID: 15118174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential significance of CX3CR1 dynamics in stress resilience against neuronal disorders.
    Inoue K
    Neural Regen Res; 2022 Oct; 17(10):2153-2156. PubMed ID: 35259822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Fractalkine Signaling Exacerbates Axon Transport Dysfunction in a Chronic Model of Glaucoma.
    Breen KT; Anderson SR; Steele MR; Calkins DJ; Bosco A; Vetter ML
    Front Neurosci; 2016; 10():526. PubMed ID: 27932942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease.
    Moatti D; Faure S; Fumeron F; Amara Mel-W; Seknadji P; McDermott DH; Debré P; Aumont MC; Murphy PM; de Prost D; Combadière C
    Blood; 2001 Apr; 97(7):1925-8. PubMed ID: 11264153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice.
    Staniland AA; Clark AK; Wodarski R; Sasso O; Maione F; D'Acquisto F; Malcangio M
    J Neurochem; 2010 Aug; 114(4):1143-57. PubMed ID: 20524966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Distribution of HIV-1 coreceptor CX3CR1 allelic polymorphisms in general population, HIV-1 high-risk group and HIV-1 carriers of Chinese indigenous Han and Uygur people].
    Liu MX; Wang FS; Hong WG; Wang CQ; Wang B; Jin L; Hou J; Lei ZY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):595-8. PubMed ID: 12975017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.